8-KRegulation FD

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Sep 10, 2004)

Filed September 10, 2004For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K report on September 10, 2004, to inform investors about upcoming meetings between its senior management and investors/analysts. These meetings, scheduled for late September and early October 2004, will focus on the company's strategy, operational tactics, and future outlook. A key takeaway for investors is the reaffirmation of UnitedHealth Group's publicly disclosed 2004 financial expectations. While the report does not introduce new financial figures, it signals management's confidence in meeting its previously stated targets during a period of discussion about the company's strategic direction.

Key Highlights

  • 1Senior management, including the CEO and COO, will be meeting with investors and analysts.
  • 2These meetings are scheduled for the latter half of September and the first half of October 2004.
  • 3The discussions will cover UnitedHealth Group's strategy, tactics, and future outlook.
  • 4The company will reaffirm its previously disclosed 2004 financial expectations.
  • 5The report serves as a Regulation FD disclosure, ensuring broad public dissemination of information.
  • 6Forward-looking statements may be made during these discussions, subject to typical risks and uncertainties.

Frequently Asked Questions

The primary purpose of this 8-K filing is to serve as a Regulation FD disclosure, informing the public that UnitedHealth Group's senior management will be meeting with investors and analysts and will be discussing the company's strategy, tactics, and future outlook.

This filing does not announce new financial results. However, it does state that management will be reaffirming the company's publicly disclosed 2004 financial expectations, indicating confidence in meeting prior guidance.

The Chairman and Chief Executive Officer, William W. McGuire, M.D., the President and Chief Operating Officer, Stephen J. Hemsley, and other senior members of the company's management team will be participating.

The report cautions that actual results could differ materially from management's expectations due to various risks and uncertainties. A detailed description of these risks can be found in UnitedHealth Group's other SEC filings, such as its annual reports on Form 10-K and quarterly reports on Form 10-Q.